Department of Radiology

Publications

2018

Sindelar M, Dyke JP, Deeb RS, Sondhi D, Kaminsky SM, Kosofsky BE, et al. Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease). Sci Rep. 2018;8(1):15229.

Puig J, Blasco G, Alberich-Bayarri A, Schlaug G, Deco G, Biarnes C, et al. Resting-State Functional Connectivity Magnetic Resonance Imaging and Outcome After Acute Stroke. Stroke. 2018;49(10):2353-2360.

Eich TS, Gonçalves BM, Nee DE, Razlighi Q, Jonides J, Stern Y. Inhibitory Selection Mechanisms in Clinically Healthy Older and Younger Adults. J Gerontol B Psychol Sci Soc Sci. 2018;73(4):612-621.

Butler T, Harvey P, Deshpande A, Tanzi E, Li Y, Tsui W, et al. Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease. Neurobiol Aging. 2018;65:201-205.

Heacock L, Lewin AA, Gao Y, Babb JS, Heller SL, Melsaether AN, et al. Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness. J Magn Reson Imaging. 2018;47(6):1692-1700.

Cheal SM, Xu H, Guo H-, Patel M, Punzalan B, Fung EK, et al. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma. Theranostics. 2018;8(18):5106-5125.

Chiang GC, Kovanlikaya I, Choi C, Ramakrishna R, Magge R, Shungu DC. Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma. Front Neurol. 2018;9:33.

Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, et al. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. Neurology. 2018;90(20):e1789-e1798.

Lee TS, Kim Y, Zhang W, Song IH, Tung C-. Facile metabolic glycan labeling strategy for exosome tracking. Biochim Biophys Acta Gen Subj. 2018;1862(5):1091-1100.

Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, et al. AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Hum Gene Ther Clin Dev. 2018;29(1):24-47.